Matthew Blischak

Amministratore Delegato presso FINCH THERAPEUTICS GROUP, INC.

Consumer Services

Health Technology

Health Services

Profilo

Matthew P.
Blischak is currently the President, Chief Executive Officer & Secretary at Finch Therapeutics Group, Inc. Prior to his current position, he served as the Vice President-Intellectual Property at Roivant Sciences, Inc. from 2018 to 2023.
Mr. Blischak completed his undergraduate degree at Case Western Reserve University and his graduate degrees at The Johns Hopkins University and American University Washington College of Law.

Posizioni attive di Matthew Blischak

Società	Posizione	Inizio
FINCH THERAPEUTICS GROUP, INC.	Amministratore Delegato	16/05/2023

Tutte le posizioni attive di Matthew Blischak

Precedenti posizioni note di Matthew Blischak

Società	Posizione	Fine
Roivant Sciences, Inc. Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs	Corporate Officer/Principal	01/04/2023

Vedi nel dettaglio l'esperienza di Matthew Blischak

Formazione di Matthew Blischak

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Matthew Blischak

Società collegate

Aziende private	5
Case Western Reserve University Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The Johns Hopkins University The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
American University Washington College of Law American University Washington College of Law Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Roivant Sciences, Inc. Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs	Health Technology
Finch Therapeutics Group, Inc. Finch Therapeutics Group, Inc. Medical/Nursing ServicesHealth Services Provides microbial therapy services	Health Services